The genotypic characteristics of this prostate cancer variant are highly variable and also show the expression of genes that are used as markers for neuroendocrine (NE) differentiation, e.g., synaptophysin (SYP), chromogranin A (CgA), and enolase 2 (ENO2) [9]. This evidence concerns the gene ENO2 and Familial prostate cancer.